Tokyo Tape
Sign in
← Takeda Pharmaceutical

Annual report

4502.TEDINET S100OBQE
Period2021-04-01 → 2022-03-31
Filed2022-06-29
StandardIFRS
ConsolidatedYes
Data checks21 of 21 passed
Key figures · 157
MetricValuePeriodScopeSource row
Revenue¥3.57T2021-04-01 → 2022-03-31Cons.Revenue IFRS
Revenue¥3.20T2020-04-01 → 2021-03-31Cons.Revenue IFRS
Revenue¥3.29T2019-04-01 → 2020-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥2.10T2018-04-01 → 2019-03-31dCons.Revenue IFRS (5-year summary)
Revenue¥1.77T2017-04-01 → 2018-03-31dCons.Revenue IFRS (5-year summary)
Operating income¥460.8bn2021-04-01 → 2022-03-31Cons.Operating profit loss IFRS
Operating income¥509.3bn2020-04-01 → 2021-03-31Cons.Operating profit loss IFRS
Profit before tax¥302.6bn2021-04-01 → 2022-03-31Cons.Profit loss before tax IFRS
Profit before tax¥366.2bn2020-04-01 → 2021-03-31Cons.Profit loss before tax IFRS
Profit before tax−¥60.8bn2019-04-01 → 2020-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥127.6bn2018-04-01 → 2019-03-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥217.2bn2017-04-01 → 2018-03-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥230.1bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥376.0bn2020-04-01 → 2021-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥44.2bn2019-04-01 → 2020-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥135.2bn2018-04-01 → 2019-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥186.9bn2017-04-01 → 2018-03-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥230.2bn2021-04-01 → 2022-03-31Cons.Profit loss IFRS
Net income¥376.2bn2020-04-01 → 2021-03-31Cons.Profit loss IFRS
Net income¥44.3bn2019-04-01 → 2020-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥135.1bn2018-04-01 → 2019-03-31dCons.Profit loss IFRS (5-year summary)
Net income¥186.7bn2017-04-01 → 2018-03-31dCons.Profit loss IFRS (5-year summary)
Total assets¥13.18Tat 2022-03-31Cons.Assets IFRS
Total assets¥12.91Tat 2021-03-31Cons.Assets IFRS
Total assets¥12.82Tat 2020-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥13.79Tat 2019-03-31dCons.Total assets IFRS (5-year summary)
Total assets¥4.11Tat 2018-03-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥7.49Tat 2022-03-31Cons.Liabilities IFRS
Total liabilities¥7.74Tat 2021-03-31Cons.Liabilities IFRS
Net assets / equity¥5.68Tat 2022-03-31Cons.Equity IFRS
Net assets / equity¥5.18Tat 2021-03-31Cons.Equity IFRS
Net assets / equity¥4.73Tat 2020-03-31dCons.Equity IFRS
Equity (owners)¥5.68Tat 2022-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥5.17Tat 2021-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥849.7bnat 2022-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥966.2bnat 2021-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥637.6bnat 2020-03-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥702.1bnat 2019-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥294.5bnat 2018-03-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥1.12T2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥1.01T2020-04-01 → 2021-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥669.8bn2019-04-01 → 2020-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥328.5bn2018-04-01 → 2019-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥377.9bn2017-04-01 → 2018-03-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow−¥198.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥393.5bn2020-04-01 → 2021-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥292.1bn2019-04-01 → 2020-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.84T2018-04-01 → 2019-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥93.3bn2017-04-01 → 2018-03-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥1.07T2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.09T2020-04-01 → 2021-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥1.01T2019-04-01 → 2020-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥2.95T2018-04-01 → 2019-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥326.2bn2017-04-01 → 2018-03-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥147.142021-04-01 → 2022-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥240.722020-04-01 → 2021-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥28.412019-04-01 → 2020-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥140.612018-04-01 → 2019-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥239.352017-04-01 → 2018-03-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥145.872021-04-01 → 2022-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥238.962020-04-01 → 2021-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥28.252019-04-01 → 2020-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥139.822018-04-01 → 2019-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥237.562017-04-01 → 2018-03-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥3,665.61at 2022-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,308.93at 2021-03-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,032.22at 2020-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥3,332.94at 2019-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥2,556.51at 2018-03-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio43.1%at 2022-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio40.1%at 2021-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio36.8%at 2020-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio37.6%at 2019-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio48.6%at 2018-03-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE4.2%2021-04-01 → 2022-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE7.6%2020-04-01 → 2021-03-31Cons.Rate of return on equity IFRS (5-year summary)
ROE0.9%2019-04-01 → 2020-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE3.8%2018-04-01 → 2019-03-31dCons.Rate of return on equity IFRS (5-year summary)
ROE9.6%2017-04-01 → 2018-03-31dCons.Rate of return on equity IFRS (5-year summary)
Employees47,347at 2022-03-31Cons.Number of employees
Employees47,099at 2021-03-31Cons.Number of employees
Employees47,495at 2020-03-31dCons.Number of employees
Employees49,578at 2019-03-31dCons.Number of employees
Employees27,230at 2018-03-31dCons.Number of employees
Revenue¥764.3bn2021-04-01 → 2022-03-31StandaloneNet sales
Revenue¥602.6bn2020-04-01 → 2021-03-31StandaloneNet sales
Revenue¥616.3bn2019-04-01 → 2020-03-31dStandaloneNet sales (5-year summary)
Revenue¥651.3bn2018-04-01 → 2019-03-31dStandaloneNet sales (5-year summary)
Revenue¥659.5bn2017-04-01 → 2018-03-31dStandaloneNet sales (5-year summary)
Operating income¥293.7bn2021-04-01 → 2022-03-31StandaloneOperating income
Operating income¥121.1bn2020-04-01 → 2021-03-31StandaloneOperating income
Ordinary income¥550.9bn2021-04-01 → 2022-03-31StandaloneOrdinary income
Ordinary income¥50.0bn2020-04-01 → 2021-03-31StandaloneOrdinary income
Ordinary income¥72.3bn2019-04-01 → 2020-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥17.5bn2018-04-01 → 2019-03-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥125.9bn2017-04-01 → 2018-03-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥371.9bn2021-04-01 → 2022-03-31StandaloneIncome before income taxes
Profit before tax¥235.5bn2020-04-01 → 2021-03-31StandaloneIncome before income taxes
Net income¥324.4bn2021-04-01 → 2022-03-31StandaloneProfit loss
Net income¥247.5bn2020-04-01 → 2021-03-31StandaloneProfit loss
Net income¥130.6bn2019-04-01 → 2020-03-31dStandaloneNet income loss (5-year summary)
Net income¥88.2bn2018-04-01 → 2019-03-31dStandaloneNet income loss (5-year summary)
Net income¥187.0bn2017-04-01 → 2018-03-31dStandaloneNet income loss (5-year summary)
Total assets¥9.64Tat 2022-03-31StandaloneAssets
Total assets¥10.86Tat 2021-03-31StandaloneAssets
Total assets¥10.29Tat 2020-03-31dStandaloneTotal assets (5-year summary)
Total assets¥9.53Tat 2019-03-31dStandaloneTotal assets (5-year summary)
Total assets¥2.95Tat 2018-03-31dStandaloneTotal assets (5-year summary)
Total liabilities¥5.35Tat 2022-03-31StandaloneLiabilities
Total liabilities¥6.42Tat 2021-03-31StandaloneLiabilities
Net assets / equity¥4.29Tat 2022-03-31StandaloneNet assets
Net assets / equity¥4.43Tat 2021-03-31StandaloneNet assets
Net assets / equity¥4.55Tat 2020-03-31dStandaloneNet assets
Net assets / equity¥4.65Tat 2019-03-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.57Tat 2018-03-31dStandaloneNet assets (5-year summary)
Cash and deposits¥287.1bnat 2022-03-31StandaloneCash and deposits
Cash and deposits¥274.0bnat 2021-03-31StandaloneCash and deposits
EPS (basic)¥207.52021-04-01 → 2022-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥158.452020-04-01 → 2021-03-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥83.882019-04-01 → 2020-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥91.762018-04-01 → 2019-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥239.472017-04-01 → 2018-03-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥207.52021-04-01 → 2022-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥158.442020-04-01 → 2021-03-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥83.872019-04-01 → 2020-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥91.722018-04-01 → 2019-03-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥239.182017-04-01 → 2018-03-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥1802021-04-01 → 2022-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802020-04-01 → 2021-03-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥1802019-04-01 → 2020-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802018-04-01 → 2019-03-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥1802017-04-01 → 2018-03-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥2,769.31at 2022-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,835.81at 2021-03-31StandaloneNet assets per share (5-year summary)
Net assets per share¥2,919.21at 2020-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,987.94at 2019-03-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥2,002.29at 2018-03-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.5%at 2022-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio40.8%at 2021-03-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio44.2%at 2020-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio48.7%at 2019-03-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio53.1%at 2018-03-31dStandaloneEquity to asset ratio (5-year summary)
ROE7.4%2021-04-01 → 2022-03-31StandaloneRate of return on equity (5-year summary)
ROE5.5%2020-04-01 → 2021-03-31StandaloneRate of return on equity (5-year summary)
ROE2.8%2019-04-01 → 2020-03-31dStandaloneRate of return on equity (5-year summary)
ROE2.8%2018-04-01 → 2019-03-31dStandaloneRate of return on equity (5-year summary)
ROE12.1%2017-04-01 → 2018-03-31dStandaloneRate of return on equity (5-year summary)
Shares issued1,582,253,000at 2022-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,388,000at 2021-03-31StandaloneTotal number of issued shares (5-year summary)
Shares issued1,576,374,000at 2020-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued1,565,006,000at 2019-03-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued794,688,000at 2018-03-31dStandaloneTotal number of issued shares (5-year summary)
Employees5,149at 2022-03-31StandaloneNumber of employees
Employees4,966at 2021-03-31StandaloneNumber of employees
Employees5,350at 2020-03-31dStandaloneNumber of employees
Employees5,291at 2019-03-31dStandaloneNumber of employees
Employees5,461at 2018-03-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 2
SegmentItemPeriodValue
Pharmaceutical Businessreportable segmentemployeesat 2022-03-3147347 pure
Pharmaceutical Businessreportable segmentemployeesat 2022-03-315149 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,724
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentYearInstant22932900
Shareholding ratio treasury shares etcCurrentYearInstant0.0145
Number of male directors and other officersFilingDateInstant13
Number of female directors and other officersFilingDateInstant2
Ratio of female directors and other officersFilingDateInstant0.13
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ChristopheWeberMember491400
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000IwasakiMasatoMember61496
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000AndrewPlumpMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000ConstantineSaroukosMember52300
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000IijimaMasamiMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000OlivierBohuonMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000JeanLucButelMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000IanClarkMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000StevenGillisMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000JohnMaraganoreMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000MichelOrsingerMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000HatsukawaKojiMember3100
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000FujimoriYoshiakiMember5600
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000HigashiEmikoMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E00919-000KimberlyReedMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant613896
Audit fees reporting companyPrior1YearDuration2465000000JPY
Non audit fees reporting companyPrior1YearDuration－JPY
Audit fees reporting companyCurrentYearDuration2358000000JPY
Non audit fees reporting companyCurrentYearDuration31000000JPY
Audit fees consolidated subsidiariesPrior1YearDuration22000000JPY
Non audit fees consolidated subsidiariesPrior1YearDuration4000000JPY
Audit fees consolidated subsidiariesCurrentYearDuration9000000JPY
Non audit fees consolidated subsidiariesCurrentYearDuration－JPY
Audit fees totalPrior1YearDuration2487000000JPY
Non audit fees totalPrior1YearDuration4000000JPY
Audit fees totalCurrentYearDuration2366000000JPY
Non audit fees totalCurrentYearDuration31000000JPY
Audit fees reporting company network firmsPrior1YearDuration－JPY
Non audit fees reporting company network firmsPrior1YearDuration－JPY
Audit fees reporting company network firmsCurrentYearDuration－JPY
Non audit fees reporting company network firmsCurrentYearDuration－JPY
Audit fees consolidated subsidiaries network firmsPrior1YearDuration1210000000JPY
Non audit fees consolidated subsidiaries network firmsPrior1YearDuration31000000JPY
Audit fees consolidated subsidiaries network firmsCurrentYearDuration1212000000JPY
Non audit fees consolidated subsidiaries network firmsCurrentYearDuration12000000JPY
Audit fees total network firmsPrior1YearDuration1210000000JPY
Non audit fees total network firmsPrior1YearDuration31000000JPY
Audit fees total network firmsCurrentYearDuration1212000000JPY
Non audit fees total network firmsCurrentYearDuration12000000JPY
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember2680000000JPY
Base remuneration remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember518000000JPY
Bonus remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember426000000JPY
Performance linked share awards remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember1182000000JPY
Restricted share awards remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember554000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 21 passed
balance sheet identityconsolidated 2021-03-31pass
balance sheet identityconsolidated 2022-03-31pass
balance sheet identitynon_consolidated 2021-03-31pass
balance sheet identitynon_consolidated 2022-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-03-31pass
statement vs summary · net assetsnon_consolidated 2021-03-31pass
statement vs summary · net assetsnon_consolidated 2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2020-04-01/2021-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2020-04-01/2021-03-31pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenueconsolidated 2020-04-01/2021-03-31pass
statement vs summary · revenueconsolidated 2021-04-01/2022-03-31pass
statement vs summary · revenuenon_consolidated 2020-04-01/2021-03-31pass
statement vs summary · revenuenon_consolidated 2021-04-01/2022-03-31pass
statement vs summary · total assetsconsolidated 2021-03-31pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsnon_consolidated 2021-03-31pass
statement vs summary · total assetsnon_consolidated 2022-03-31pass